Fate Therapeutics Inc (NAS:FATE)
$ 3.16 -0.06 (-1.86%) Market Cap: 359.71 Mil Enterprise Value: 78.24 Mil PE Ratio: 0 PB Ratio: 0.84 GF Score: 59/100

Fate Therapeutics Inc (FATE) Transcripts

  • 1